Literature DB >> 18262306

TLR9 as a key receptor for the recognition of DNA.

Yutaro Kumagai1, Osamu Takeuchi, Shizuo Akira.   

Abstract

Unmethylated DNA with CpG-motifs is recognized by Toll-like receptor 9 (TLR9) and pleiotropic immune responses are elicited. Macrophages and conventional dendritic cells (cDCs) produce proinflammatory cytokines to B/K-type CpG-DNA, whereas plasmacytoid DCs induce type I interferons to A/D-type CpG-DNA and DNA viruses. The TLR9 mediated signaling pathway is not only responsible for activation of innate immune cells, but also for mounting acquired responses. Thus, it has been attempted to exploit TLR9 ligands as a vaccine adjuvant for anti-cancer immunotherapy. Further, TLR9 mediated signaling is implicated in the pathogenesis of autoimmune diseases such as systemic lupus erythematosus. Nevertheless, recent studies revealed that double-stranded DNA can be recognized by intracellular receptor(s) in a TLR9-independent manner. This review will focus on the roles of TLR9 in immune responses, and its signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262306     DOI: 10.1016/j.addr.2007.12.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  105 in total

1.  Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Authors:  Jeremy M Luke; Gregory G Simon; Jonas Söderholm; John S Errett; J Thomas August; Michael Gale; Clague P Hodgson; James A Williams
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

2.  DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines.

Authors:  S E Sahingur; X-J Xia; S Alamgir; K Honma; A Sharma; H A Schenkein
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

3.  Cell-Free DNA Release by Mouse Fetal Membranes.

Authors:  Michala R Sawyer; Sharareh Adeli; Mark Phillippe
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

4.  Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Authors:  Valentina Di Caro; Antonella D'Anneo; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 5.  In life there is death: How epithelial tissue barriers are preserved despite the challenge of apoptosis.

Authors:  Kinga Duszyc; Guillermo A Gomez; Kate Schroder; Matthew J Sweet; Alpha S Yap
Journal:  Tissue Barriers       Date:  2017-07-07

Review 6.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

7.  Toll-like receptor 9 and 21 have different ligand recognition profiles and cooperatively mediate activity of CpG-oligodeoxynucleotides in zebrafish.

Authors:  Da-Wei Yeh; Yi-Ling Liu; Yin-Chiu Lo; Chiou-Hwa Yuh; Guann-Yi Yu; Jeng-Fan Lo; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

8.  Fibroblasts express immune relevant genes and are important sentinel cells during tissue damage in rainbow trout (Oncorhynchus mykiss).

Authors:  Hans-Christian Ingerslev; Carlo Gunnar Ossum; Thomas Lindenstrøm; Michael Engelbrecht Nielsen
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

9.  Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity.

Authors:  Petra Cerkovnik; Barbara Jezersek Novakovic; Vida Stegel; Srdjan Novakovic
Journal:  BMC Immunol       Date:  2010-09-13       Impact factor: 3.615

10.  Neonate intestinal immune response to CpG oligodeoxynucleotide stimulation.

Authors:  Sonia Lacroix-Lamandé; Nicolas Rochereau; Roselyne Mancassola; Mathieu Barrier; Amandine Clauzon; Fabrice Laurent
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.